Literature DB >> 10830913

Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.

D J Lehmann1, Z Nagy, S Litchfield, M C Borja, A D Smith.   

Abstract

In confirmed late-onset (>65 years) Alzheimer's disease, we found a greater load, both of overall neuritic plaques and of cholinesterase-positive neuritic plaques, in the temporal cortex of carriers of the butyrylcholinesterase K variant (BCHE-K) aged <80 years than of all other patients. The differences were most striking in the case of cholinesterase-positive neuritic plaques. Among BCHE-K carriers, densities of such plaques were over six times higher in patients <80 years at death than in those >80 years (P=0.01). Furthermore, in subjects <80 years, BCHE-K carriers had nearly six-fold greater densities of these plaques than non-carriers (P=0.009). We consider three potential explanations for these findings: that the K variant binds more readily to plaque constituents, that it promotes fibril formation or that it induces aberrant neurite growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10830913     DOI: 10.1007/s004390000277

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  Association of BDNF and BCHE with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.

Authors:  Huihui Ji; Dongjun Dai; Yunliang Wang; Danjie Jiang; Xingyu Zhou; Peipei Lin; Xiaosui Ji; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Rongrong Chen; Lina Zhang; Mingqing Xu; Shiwei Duan; Qinwen Wang
Journal:  Exp Ther Med       Date:  2015-03-03       Impact factor: 2.447

2.  Amyloid beta peptide processing, insulin degrading enzyme, and butyrylcholinesterase.

Authors:  A S Balasubramanian
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

3.  Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.

Authors:  Asad Vaisi-Raygani; Zohreh Rahimi; Haidar Tavilani; Tayebeh Pourmotabbed
Journal:  Mol Biol Rep       Date:  2009-08-15       Impact factor: 2.316

4.  A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.

Authors:  Agneta Nordberg; Clive Ballard; Roger Bullock; Taher Darreh-Shori; Monique Somogyi
Journal:  Prim Care Companion CNS Disord       Date:  2013-03-07

5.  Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.

Authors:  Ahmadul Kadir; Amelia Marutle; Daniel Gonzalez; Michael Schöll; Ove Almkvist; Malahat Mousavi; Tamanna Mustafiz; Taher Darreh-Shori; Inger Nennesmo; Agneta Nordberg
Journal:  Brain       Date:  2010-12-13       Impact factor: 13.501

6.  Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.

Authors:  Shani Shenhar-Tsarfaty; Tal Bruck; Estelle R Bennett; Tsafrir Bravman; Einor Ben Aassayag; Nir Waiskopf; Ori Rogowski; Natan Bornstein; Shlomo Berliner; Hermona Soreq
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

7.  Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.

Authors:  Marcella Reale; Erica Costantini; Marta Di Nicola; Chiara D'Angelo; Sara Franchi; Marco D'Aurora; Maria Di Bari; Viviana Orlando; Sabrina Galizia; Serena Ruggieri; Liborio Stuppia; Claudio Gasperini; Ada Maria Tata; Valentina Gatta
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

8.  Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.

Authors:  Jacek Jasiecki; Anna Limon-Sztencel; Monika Żuk; Magdalena Chmara; Dominik Cysewski; Janusz Limon; Bartosz Wasąg
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

9.  Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.

Authors:  Swetha Vijayaraghavan; Azadeh Karami; Shahin Aeinehband; Homira Behbahani; Alf Grandien; Bo Nilsson; Kristina N Ekdahl; Rickard P F Lindblom; Fredrik Piehl; Taher Darreh-Shori
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

10.  Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.

Authors:  Rajnish Kumar; Agneta Nordberg; Taher Darreh-Shori
Journal:  Brain       Date:  2015-11-02       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.